Buxton Helmsley Issues Letter To Assertio Holdings, Inc; Calls For The Immediate Resignation Of Four Directors, Including Chairman Peter Staple, Heather Mason, William Mckee And Dr. Jeffrey Vacirca
Buxton Helmsley Issues Letter To Assertio Holdings, Inc; Calls For The Immediate Resignation Of Four Directors, Including Chairman Peter Staple, Heather Mason, William Mckee And Dr. Jeffrey Vacirca
Calls for the Immediate Resignation of Four Directors, Including Chairman Peter Staple, Heather Mason, William McKee and Dr. Jeffrey Vacirca
呼籲四名董事，包括主席彼得·斯特普爾、海瑟·梅森、威廉·麥基和傑弗裏·瓦奇卡立即辭職。
Intends to Nominate Independent, Qualified Directors at the Company's Next Shareholder Meeting If No Progress is Made
如果沒有任何進展，公司下一次股東會議將打算提名獨立，合格的董事。
Criticizes Board's Failure to Explain and Recover Damages From Value-Destructive Spectrum Pharmaceuticals Acquisition
批評董事會未能說明和收回價值破壞性的Spectrum Pharmaceuticals收購所造成的損失。
Urges Board to Improve its Due Diligence Process Before Any Further M&A
敦促董事會在任何進一步的併購之前改善其盡職調查流程。
The Buxton Helmsley Group, Inc., a significant shareholder of Assertio Holdings, Inc. (NASDAQ:ASRT), today issued the following letter to the company's Board of Directors.
Assertio Holdings股東Buxton Helmsley Group，Inc. (NASDAQ:ASRT)今日向公司董事會發出以下公開信。